Skip to main content
. 2001 May 1;98(10):5898–5903. doi: 10.1073/pnas.101116598

Figure 3.

Figure 3

The response of 1138H bitransgenic mouse lungs to the induction of FGF-3 for 4 weeks with varying doses of RU486. (A) H&E-stained section of lung from placebo-treated 1138H bitransgenic mouse. (B) H&E-stained section of lungs from 1138H bitransgenic mouse treated with 130 μg/kg RU486. FAMs are abundant. (C) H&E-stained section of lungs from 1138H bitransgenic mouse treated with 200 μg/kg RU486. Type II cell hyperplasia is apparent.